Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESUME: Pomalidomide in MPN-associated Myelofibrosis
NCT01178281Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Sep 2010
- Primary completion
- Jan 2013
- Modality
- Molecular Glues
- Countries
- 16
01
Overview
A Phase 3 trial of pomalidomide in myelofibrosis (MF), sponsored by Celgene Corporation. Started Sep 2010; status: completed.
02
Drugs
pomalidomide
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT01178281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178281.